Atlas Trials

Alzheimer's Disease (AD)

47 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Alzheimer's Disease (AD)

RecordFirmDate
Amyloid-β Clearance Mechanisms in Alzheimer's Disease (NCT05059158)Ludwig-Maximilians - University of Munich2021-06-01
Effects of Auditory Brain Stimulation by "Pink Noise" on Memory Capacities in Alzheimer's Disease: Proof of Concept Study (NCT04570761)University Hospital, Tours2021-03-11
UPenn Observational Research Repository on Neurodegenerative Disease (NCT04715399)University of Pennsylvania2020-05-29
A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355 (NCT03802162)Chong Kun Dang Pharmaceutical2019-02-15
A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease (NCT07307872)Amoneta Diagnostics SAS2017-03-23
Alzheimer's Disease Neuroimaging Initiative 3 (NCT02854033)University of Southern California2016-12-02
Cognitive-motor Intervention Using Virtual Reality for Middle-aged Individuals at High Dementia Risk (NCT02832921)Sheba Medical Center2016-07-01
Trial of Oxaloacetate in Alzheimer's Disease (TOAD) (NCT02593318)Russell Swerdlow2015-10-01
Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With AD (NCT02681172)Piramal Imaging Limited2015-10-01
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease (NCT02503501)HealthPartners Institute2015-09-28
Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies (NCT02531360)Molecular NeuroImaging2015-05-01
Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease (NCT02370524)Molecular NeuroImaging2015-01-01
MEMENTO-VAScular COmponents of Dementia (NCT02264899)University Hospital, Bordeaux2014-11-04
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects (NCT02103894)Molecular NeuroImaging2014-02-01
The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms (NCT01780519)Mayo Clinic2013-01-01
Alzheimer's Disease Neuroimaging Initiative 2 (NCT01231971)University of Southern California2011-02-14

Track Alzheimer's Disease (AD) automatically

Every clearance here is in the API, with alerts when new ones post.